13.63 USD
▼-0.13-0.94%
盘后 14.49 0.00%
2026-09-15
市值
$760.16M
市盈率
—
EPS
-2.77
股息率
—
52 周区间
6.47 – 16.93
成交量
552.03K
Beta
2.73
目标价
29.10
52W 低 6.4752W 高 16.93
价格走势
公司简介
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company’s lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is...